N-ASSAY TIA IGG— 510(k) K933972

Substantially Equivalent

Crestat Diagnostics, Inc.

FDA 510(k) clearance K933972 for N-ASSAY TIA IGG, Substantially Equivalent on 1994-03-22. Applicant: Crestat Diagnostics, Inc.. Device class: 2.

Clearance details

Applicant: Crestat Diagnostics, Inc.
Product code: Code CFF
Device class: Class 2
Regulation: 21 CFR 866.5510
Advisory panel: Immunology
Date received: 1993-08-13
Decision date: 1994-03-22
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Thousand Oaks, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code CFF

K203184 — HYDRASHIFT 2/4 isatuximab2021-11-12
K192095 — CAPI 3 Immunotyping, Capillarys 3 Tera2019-11-01
K190851 — HYDRASHIFT 2/4 daratumumab2019-05-02
K172195 — HYDRASHIFT 2/4 daratumumab, daratumumab Control2018-01-11
K161928 — CAPI 3 IMMUNOTYPING, CAPILLARYS 3 TERA, IT/IF CONTROL2016-12-21

More clearances from Crestat Diagnostics, Inc.

Data sourced from openFDA. This site is unofficial and independent of the FDA.